home / stock / gntlf / gntlf quote
Last: | $0.0007 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0007 |
Close: | $0.0007 |
High: | $0.0007 |
Low: | $0.0007 |
Volume: | 2,000 |
Last Trade Date Time: | 11/06/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0007 | $0.0007 | $0.0007 | $0.0007 | $0.0007 | 2,000 | 11-06-2023 |
$0.0634 | $0.0634 | $0.0634 | $0.0634 | $0.0634 | 1,000 | 08-21-2023 |
$0.0015 | $0.0015 | $0.0015 | $0.0015 | $0.0015 | 1,000 | 05-10-2023 |
$0.01 | $0.06 | $0.01 | $0.06 | $0.01 | 6,000 | 03-02-2023 |
$0.001 | $0.06 | $0.001 | $0.06 | $0.001 | 450 | 02-10-2023 |
$0.004 | $0.004 | $0.004 | $0.004 | $0.004 | 10,000 | 02-03-2023 |
$0.004 | $0.002 | $0.004 | $0.004 | $0.002 | 179,825 | 12-19-2022 |
$0.002 | $0.0025 | $0.002 | $0.0025 | $0.001 | 135,000 | 12-13-2022 |
$0.0015 | $0.0015 | $0.0015 | $0.0015 | $0.0015 | 50,000 | 11-02-2022 |
$0.0032 | $0.0032 | $0.0032 | $0.0032 | $0.0032 | 40,000 | 09-15-2022 |
$0.0035 | $0.0035 | $0.0035 | $0.0035 | $0.0035 | 9,000 | 08-26-2022 |
$0.004 | $0.004 | $0.004 | $0.004 | $0.004 | 1,000 | 08-25-2022 |
$0.0025 | $0.0065 | $0.0025 | $0.0065 | $0.0025 | 30,000 | 06-22-2022 |
$0.006 | $0.006 | $0.006 | $0.006 | $0.006 | 28,800 | 06-20-2022 |
$0.006 | $0.006 | $0.006 | $0.006 | $0.006 | 28,800 | 06-17-2022 |
$0.005 | $0.005 | $0.005 | $0.005 | $0.005 | 91,200 | 06-16-2022 |
$0.002 | $0.002 | $0.002 | $0.002 | $0.002 | 1,000 | 10-21-2021 |
$0.008 | $0.008 | $0.008 | $0.008 | $0.008 | 50,000 | 08-26-2021 |
$0.005 | $0.005 | $0.005 | $0.005 | $0.005 | 610 | 07-16-2021 |
$0.003 | $0.003 | $0.003 | $0.003 | $0.003 | 5,000 | 07-08-2021 |
News, Short Squeeze, Breakout and More Instantly...
Genetic Techs Ltd Aud Company Name:
GNTLF Stock Symbol:
OTCMKTS Market:
MELBOURNE, Australia, April 30, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, releases its Appendix 4C and Quarterly b...
MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, t...
MELBOURNE, Australia, April 19, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies"), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today announced that it has entered into a ...